Killer cell immunoglobulin-like receptor expression induction on neonatal CD8(+) T cells in vitro and following congenital infection with Trypanosoma cruzi

Immunology. 2010 Mar;129(3):418-26. doi: 10.1111/j.1365-2567.2009.03194.x. Epub 2009 Nov 16.

Abstract

Major histocompatibility complex (MHC) class I-specific inhibitory natural killer receptors (iNKRs) are expressed by subsets of T cells but the mechanisms inducing their expression are poorly understood, particularly for killer-cell immunoglobulin-like receptors (KIRs). The iNKRs are virtually absent from the surface of cord blood T cells but we found that KIR expression could be induced upon interleukin-2 stimulation in vitro. In addition, KIR expression was enhanced after treatment with 5-aza-2'-deoxycytidine, suggesting a role for DNA methylation. In vivo induction of KIR expression on cord blood T cells was also observed during a human congenital infection with Trypanosoma cruzi which triggers activation of fetal CD8(+) T cells. These KIR(+) T cells had an effector and effector/memory phenotype suggesting that KIR expression was consecutive to the antigenic stimulation; however, KIR was not preferentially found on parasite-specific CD8(+) T cells secreting interferon-gamma upon in vitro restimulation with live T. cruzi. These findings show that KIR expression is likely regulated by epigenetic mechanisms that occur during the maturation process of cord blood T cells. Our data provide a molecular basis for the appearance of KIRs on T cells with age and they have implications for T-cell homeostasis and the regulation of T-cell-mediated immune responses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / pharmacology
  • Antigens, CD / metabolism
  • Azacitidine / analogs & derivatives
  • Azacitidine / pharmacology
  • CD3 Complex / immunology
  • CD8-Positive T-Lymphocytes / drug effects
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / metabolism*
  • Chagas Disease / congenital*
  • Chagas Disease / immunology*
  • DNA Modification Methylases / antagonists & inhibitors
  • Decitabine
  • Enzyme Inhibitors / pharmacology
  • Female
  • Fetal Blood / cytology
  • Fetal Blood / immunology
  • Humans
  • Immunophenotyping
  • Infant, Newborn
  • Infant, Newborn, Diseases / immunology*
  • Interleukin-2 / pharmacology
  • NK Cell Lectin-Like Receptor Subfamily C / metabolism
  • Pregnancy
  • Receptors, Antigen, T-Cell, alpha-beta / metabolism
  • Receptors, KIR / metabolism*
  • Receptors, KIR2DL1 / metabolism
  • Receptors, KIR2DL2 / metabolism
  • Receptors, KIR2DL3 / metabolism
  • Receptors, KIR3DL1 / metabolism
  • T-Lymphocyte Subsets / immunology
  • T-Lymphocyte Subsets / metabolism
  • Trypanosoma cruzi / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • CD3 Complex
  • Enzyme Inhibitors
  • Interleukin-2
  • KIR2DL2 protein, human
  • KLRC1 protein, human
  • NK Cell Lectin-Like Receptor Subfamily C
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, KIR
  • Receptors, KIR2DL1
  • Receptors, KIR2DL2
  • Receptors, KIR2DL3
  • Receptors, KIR3DL1
  • Decitabine
  • DNA Modification Methylases
  • Azacitidine